United Therapeutics (UTHR) Proxy filing summary

Executive summary

• Annual Meeting scheduled for June 26, 2026, to be held virtually via live audio webcast.

• Shareholders are encouraged to review proxy materials and vote by June 25, 2026.

Voting matters and shareholder proposals

• Election of eleven directors, with all nominees recommended for approval.

• Advisory vote on executive compensation (say-on-pay) recommended for approval.

• Approval of the 2026 Stock Incentive Plan recommended.

• Ratification of Ernst & Young LLP as independent auditor for 2026 recommended.

Board of directors and corporate governance

• Eleven director nominees listed, including Christopher Causey, Ray Kurzweil, and Martine Rothblatt.

• Board recommends voting in favor of all director nominees.